James Kennedy
Chair and Professor, HPA 509-368-6971 HPA/SHERB/430 PO BOX 1495


  • Ph.D., University of California, Berkeley
  • Master of Art, Claremont Graduate School
  • Bachelor of Art, Whitman College


  • Disability and aging services
  • Health reform
  • Rehabilitation, and long term care policy
  • Program evaluation


National Institute on Independent Living Disability and Rehabilitation Research, $2,493,892. Collaborative on Health Reform and Independent Living (CHRIL). J Kennedy, PI. (10/15-9/20).

WA Attorney General’s Office, Consumer Protective Division, $340,288. The Antipsychotic Atlas: Medicare Usage of Antipsychotic Medications in Washington. J Kennedy, PI. [September 2013-August 2016)


  • Member (2014-present), Community Health Assessment Board, Spokane Regional Health District
  • Mentor (2015-present), AcademyHealth /Aetna Foundation Scholars in Residence Fellowship Program
  • AcademyHealth Disability Research Interest Group; Executive Committee member (2007-2011, 2014-2016), Chair (2012-2014)
  • Executive Committee (2016-present), NARRTC (formerly National Association of Research and Training Centers)
  • Editorial Board Member (1996-present), Journal of Disability Policy Studies


Kennedy, J & I Tuleu (2007). Working age Medicare beneficiaries with disabilities: population characteristics and policy considerations. Journal of Health and Human Services Administration, 30(3), 268-291

Kennedy, J, I Tuleu & K Mackay (2008). Unfilled prescriptions of Medicare beneficiaries: Prevalence, reasons, and types of medicines prescribed. Journal of Managed Care Pharmacy, 14(6), 553-560

Kennedy, J & S Morgan (2009). Cost related prescription nonadherence in the U S and Canada: a system level comparison using the 2007 International Health Perspectives Survey. Clinical Therapeutics, 31(1), 213-219

Kennedy, J, Y Tien, L Cohen, D Sclar, D Liu, E Blodgett & J Engle (2009). The association between class of antipsychotic and the rates of hospitalization: results of a retrospective analysis of the 2005 Medicare Beneficiary Survey. Clinical Therapeutics, 31(12), 2931-2939.

Kennedy, J, A Dipzinski, J Roll, J Coyne & E Blodgett (2010). Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence. Drug and Alcohol Dependence, 114(2), 201-206

Kennedy, J, M Maciejewski, D Liu, E Blodgett (2011). Cost related nonadherence in the Medicare program – the impact of Part D. Medical Care, 49(5), 522-526

Kennedy, J & E Blodgett (2012). Health Insurance–Motivated Disability Enrollment and the ACA. New England Journal of Medicine, 367, e16

Roll, J, J Kennedy, M Tran & D Howell (2013). Disparities in unmet need for mental health services in the US, 1997-2010. Psychiatric Services, 64(1), 80-82

Kennedy, J, E Blodgett & G Gimm (2013). Return to work: A critical aspect of care coordination for younger dual eligibles. Disability and Health, 6(2), 95-99

Cochran, G, J Roll, R Jackson & J Kennedy (2014). Health care reform and the behavioral health workforce. Journal of Social Work Practice in the Addictions, 14(2), 127-140

Kennedy, J, J Roll, T Schraudner, S Murphy & S McPherson (2014). Prevalence of persistent pain in the US adult population: New data from the 2010 National Health Interview Survey. Journal of Pain, 15(10), 979-984

Wu, C, C Wang & J Kennedy (2015). Alternative therapies as a substitute for costly prescription medications: Results from the 2011 National Health Interview Survey. Clinical Therapeutics, 37(5), 1022-30

Kennedy, J, G Gimm & R Glazier (2015). After CLASS – Is a voluntary public insurance program a realistic way to meet the long-term support and service needs of adults with disabilities? Disability and Health, S1936-6574(15), 00169-7